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The obesity epidemic is responsible for a substantial economic burden in developed countries and is a major risk factor
for type 2 diabetes and cardiovascular disease. The disease is the result not only of several environmental risk factors,
but also of genetic predisposition. To take advantage of recent advances in gene-mapping technology, we executed a
genome-wide association scan to identify genetic variants associated with obesity-related quantitative traits in the
genetically isolated population of Sardinia. Initial analysis suggested that several SNPs in the FTO and PFKP genes were
associated with increased BMI, hip circumference, and weight. Within the FTO gene, rs9930506 showed the strongest
association with BMI (p ¼ 8.6 310
 7), hip circumference (p ¼ 3.4 3 10
 8), and weight (p ¼ 9.1 3 10
 7). In Sardinia,
homozygotes for the rare ‘‘G’’ allele of this SNP (minor allele frequency ¼ 0.46) were 1.3 BMI units heavier than
homozygotes for the common ‘‘A’’ allele. Within the PFKP gene, rs6602024 showed very strong association with BMI (p
¼4.9310
 6). Homozygotes for the rare ‘‘A’’ allele of this SNP (minor allele frequency¼0.12) were 1.8 BMI units heavier
than homozygotes for the common ‘‘G’’ allele. To replicate our findings, we genotyped these two SNPs in the GenNet
study. In European Americans (N ¼ 1,496) and in Hispanic Americans (N ¼ 839), we replicated significant association
between rs9930506 in the FTO gene and BMI (p-value for meta-analysis of European American and Hispanic American
follow-up samples, p¼0.001), weight (p¼0.001), and hip circumference (p¼0.0005). We did not replicate association
between rs6602024 and obesity-related traits in the GenNet sample, although we found that in European Americans,
Hispanic Americans, and African Americans, homozygotes for the rare ‘‘A’’ allele were, on average, 1.0–3.0 BMI units
heavier than homozygotes for the more common ‘‘G’’ allele. In summary, we have completed a whole genome–
association scan for three obesity-related quantitative traits and report that common genetic variants in the FTO gene
are associated with substantial changes in BMI, hip circumference, and body weight. These changes could have a
significant impact on the risk of obesity-related morbidity in the general population.
Citation: Scuteri A, Sanna S, Chen W, Uda M, Albai G, et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related
traits. PLoS Genet 3(7): e115. doi:10.1371/journal.pgen.0030115
Introduction
There is a worldwide epidemic of obesity and type 2
diabetes across all age groups, especially in industrialized
countries [1]. In the United States alone, over two-thirds of
the population has a body mass index (BMI) of 25 kg/m
2 or
greater and is thus overweight [2,3]. Being overweight is a
well-established risk factor for many chronic diseases, such as
type 2 diabetes, hypertension, and cardiovascular events [4],
and increases in BMI are associated with higher all-cause
mortality [5,6]. The economic cost attributable to obesity in
the United States has been estimated to be as high as $100
billion/yr [7], and includes not only direct health care costs
but also the cost of lost productivity in affected individuals [8].
Individual susceptibility to obesity is thought to be
determined by interactions between an individual’s genetic
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increased prevalence of obesity likely reﬂects the exposure
of genetically susceptible individuals to unhealthy secular
trends in environmental and behavioral factors, such as diet
and exercise [9]. In industrialized countries, between 60%–
70% of the variation in obesity-related phenotypes appears
to be heritable [10,11].
The traditional approach for mapping disease genes relies
on linkage mapping followed by progressive ﬁne-mapping of
candidate linkage peaks [12]. While the approach has been
extremely successful at identifying genes that predispose
carriers to rare Mendelian disorders [13], it has met only
limited success when applied to complex traits such as
obesity. We have taken advantage of recent advances in
genotyping technology that enable detailed assessment of
entire genomes [14,15]. These advances have already allowed
the identiﬁcation of genes that inﬂuence quantitative
variation in heart disease–related phenotypes [16] and of
susceptibility genes for age-related macular degeneration
[17], inﬂammatory bowel disease [18], and type 2 diabetes
[19].
We recruited and phenotyped 6,148 individuals, male and
female, ages 14–102 y, from a cluster of four towns in the
Lanusei Valley in the Sardinian province of Ogliastra [20]. By
studying an isolated population, we expected to increase the
genetic and environmental homogeneity of our sample,
increasing power [21,22]. Our cohort included .30,000
relative pairs and represents .60% of the population eligible
for participation in the study; a detailed account of the family
structures we examined is available elsewhere [20]. We took
advantage of the relatedness among individuals in our sample
to substantially reduce study costs [23]. Speciﬁcally, because
our sample includes many large families, we reasoned that
genotyping a relatively small number of markers in all
individuals would allow us to identify shared haplotype
stretches within each family. We could then genotype a
subset of the individuals in each family at higher density to
characterize the haplotypes in each stretch and impute
missing genotypes in other individuals in the family [23,24].
For the analyses presented here, we genotyped 3,329
individuals using the Affymetrix 10,000 SNP Mapping Array
and we genotyped an additional 1,412 individuals using the
Affymetrix 500,000 SNP Mapping Array Set. The genotyped
individuals were selected to represent the largest families in
our sample, without respect to phenotype. The high-density
arrays were generally used to genotype both parents and one
child (in larger sibships) or just the parents (in smaller
sibships); the lower density arrays were used to genotype
everyone else. Except when parents and offspring were
genotyped in the same family, we tried to ensure that
individuals genotyped with the high-density array were only
distantly related to one another. For the 2,893 individuals
that were genotyped with the 10,000 SNP arrays only, we used
a modiﬁed version of the Lander-Green algorithm [25,26] to
probabilistically infer missing genotypes [24]. Our approach
for estimating missing genotypes is implemented in MERLIN
(http://www.sph.umich.edu/csg/abecasis/MERLIN/) and de-
scribed in detail elsewhere [24]. Our initial analysis focused
on evaluating the additive effects of 362,129 SNPs (Table S1)
that passed quality control checks [27,28]. The remaining
SNPs failed quality checks (;2.9% of SNPs failed checks for
data completeness, Hardy–Weinberg equilibrium, and Men-
delian incompatibilities) or had a minor allele frequency of
,5% (;25.7% of SNPs had low minor allele frequencies).
Results
We tested 362,129 SNPs for association with three obesity-
related quantitative traits (BMI, hip circumference, and
weight). Height was included as a covariate in analysis of
hip circumference and weight. In addition, we included age
and sex as covariates in every analysis. The genomic control
parameter [29] for our initial analysis of each trait ranged
from 1.07 to 1.09, indicating that our estimated test statistics
might be slightly inﬂated. This is likely due to unaccounted-
for distant relationships among the sampled individuals. All
results presented in our tables have been adjusted using the
method of genomic control [29]. After adjustment, we
observed no signiﬁcant excess of results exceeding liberal
signiﬁcance thresholds. For example, the proportion of test
statistics that were signiﬁcant at a ¼ 0.001 was 0.00098.
Results of our initial association analysis are summarized in
Figure 1 and in Table 1. We used the false-discovery rate
(FDR) to select a small set of very promising trait SNP
associations for rapid replication. Using an FDR [30] of 20%
highlighted a small set of SNPs for each trait. This set include
the top eight SNP association results for hip circumference
and weight (FDR¼0.013 and FDR¼0.16, respectively) and the
top nine SNP association results for BMI (FDR ¼ 0.20).
Eight of the SNPs listed in Table 1 overlap among the three
traits. In particular, SNP rs9930506 and a cluster of nearby
SNPs on Chromosome 16 show strong association with BMI (p
¼8.6310
 7), hip circumference (p¼3.4310
 8) and weight (p
¼ 9.1 3 10
 7). Two of the associated SNPs in the cluster,
rs9939609 and rs9926289, fall within an intronic region where
sequence is strongly conserved across species. For compara-
tive purposes, using a conservative Bonferroni correction
aimed at an overall type I error rate of 0.05 (one false positive
per 20 genome-scans), would result in a signiﬁcance threshold
of 1.4 3 10
 7.
This cluster of SNPs on Chromosome 16 overlaps the FTO
[31] gene, an extremely large gene whose exons span .400kb
(Figure 2). KIAA1005, a gene of unknown function, also maps
nearby. The FTO gene has not been previously implicated in
obesity, but it maps to a region where linkage to BMI has been
PLoS Genetics | www.plosgenetics.org July 2007 | Volume 3 | Issue 7 | e115 1201
FTO and Obesity
Author Summary
Although twin and family studies have clearly shown that genes
play a role in obesity, it has proven quite difficult to identify the
specific genetic variants involved. Here, we take advantage of recent
technical and methodological advances to examine the role of
common genetic variants on several obesity-related traits. By
examining .4,000 Sardinians, we show that a specific genetic
variant, rs9930506, and other nearby variants on human Chromo-
some 16 are associated with body mass index, hip circumference,
and total body weight. The variants overlap FTO, a gene with poorly
understood function. Further studies of the region may implicate
new biological pathways affecting susceptibility to obesity. We also
show that the association is not restricted to Sardinia but is also
seen in independent samples of European Americans and Hispanic
Americans. This finding is particularly important because obesity is
associated with increased risk of cardiovascular disease and
diabetes.F
i
g
u
r
e
1
.
N
e
g
a
t
i
v
e
L
o
g
o
f
p
-
V
a
l
u
e
f
o
r
S
i
n
g
l
e
M
a
r
k
e
r
A
s
s
o
c
i
a
t
i
o
n
A
n
a
l
y
s
i
s
w
i
t
h
T
h
r
e
e
O
b
e
s
i
t
y
-
R
e
l
a
t
e
d
T
r
a
i
t
s
L
o
c
a
t
i
o
n
s
o
f
P
F
K
P
a
n
d
F
T
O
g
e
n
e
s
a
r
e
h
i
g
h
l
i
g
h
t
e
d
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
g
e
n
.
0
0
3
0
1
1
5
.
g
0
0
1
PLoS Genetics | www.plosgenetics.org July 2007 | Volume 3 | Issue 7 | e115 1202
FTO and Obesityreported in two previous genome-wide linkage scans (LOD ¼
3.2 in the Framingham Heart Study [32] and LOD¼2.2 in the
families with white ancestry from the Family Blood Pressure
Program [33]). Furthermore, a syndrome that results from
deletion of this region of Chromosome 16q includes obesity
as one of its features [34].
Although multiple SNPs within FTO show evidence for
association, these do not point to multiple independently
associated SNPs—rather, it is likely they are all in disequili-
brium with the same causal variant(s). In a sequential analysis
in which we selected the best SNP for each trait and then
conditioned on it to successively select the next best SNP,
only one FTO SNP was selected (results presented in Table
S2). This result is consistent with the fact that the SNPs fall in
a region of strong linkage disequilibrium, both in Sardinia
and in the HapMap (Figure 2B).
Our FDR analysis of BMI selected one additional SNP
outside this cluster, rs6602024 (Figure 3). This SNP maps to
Chromosome 10 and shows association with BMI (p ¼ 4.9 3
10
 6), weight (1.6310
 5), and hip circumference (p¼0.00047).
The SNP maps to the platelet-type phosphofructokinase
(PFKP) gene, which acts as a major rate-limiting enzyme in
glycolysis, converting D-fructose-6-phosphate to fructose-1,6-
bisphosphate [35]. Alterations in the structure or regulation
of PFKP could alter the balance between glycolysis and
glycogen production, ultimately leading to obesity.
Table 2 shows the phenotypic effects associated with each
of the two SNPs in our sample. Because rs9930506 is more
common, it shows more signiﬁcant association despite being
associated with smaller phenotypic effects (the two homo-
zygotes differ, on average, by ;1.5 BMI units). A rarer
polymorphism, such as rs6602024, impacts only a smaller
proportion of the population and shows less signiﬁcant
association, despite a larger difference between homozygote
means (which differ, on average, by ;2.9 BMI units). In each
case, a more accurate estimate of the effect is provided by the
regression model with age, sex, and (where appropriate)
height as covariates. In a study, such as ours, that estimates
effect sizes for many SNPs, statistical ﬂuctuation means that
some estimates will be slightly high and others will be low.
SNPs that reach statistical signiﬁcance are likely to include
those for which effect size estimates are inﬂated (this is the
winner’s curse phenomenon) [36], and thus we proceeded to
replicate our top association signals in additional large
samples.
To further investigate the association between rs9930506
and rs6602024 and obesity-related traits, we genotyped these
SNPs in the GenNet study [37]. The study includes a series of
families recruited through probands with elevated blood
Table 1. Markers Showing Strongest Evidence for Association
Trait SNP Chromosome Position Allele Frequency Effect (s.d.) H
2 p-Value FDR
BMI rs9930506 16 52387966 A 0.54  0.132 1.34% 8.6E 07 0.09
rs8050136 16 52373776 C 0.54  0.129 1.28% 1.1E 06 0.09
rs1121980 16 52366748 G 0.55  0.128 1.25% 1.4E 06 0.09
rs7193144 16 52368187 T 0.54  0.127 1.24% 1.5E 06 0.09
rs9940128 16 52358255 G 0.55  0.127 1.24% 1.6E 06 0.09
rs9939973 16 52358069 G 0.55  0.127 1.24% 1.6E 06 0.09
rs9939609 16 52378028 T 0.54  0.126 1.22% 1.8E 06 0.09
rs9926289 16 52378004 C 0.54  0.123 1.17% 1.8E 06 0.15
rs6602024 10 3145237 G 0.88  0.196 1.26% 4.9E 06 0.20
rs7907949 10 3138056 G 0.90  0.198 1.12% 1.1E 05 0.40
Hip rs9930506 16 52387966 A 0.54  0.157 1.63% 3.4E 08 0.006
rs8050136 16 52373776 C 0.54  0.152 1.53% 6.8E 08 0.006
rs9939973 16 52358069 G 0.55  0.152 1.51% 8.5E 08 0.006
rs9940128 16 52358255 G 0.55  0.152 1.51% 8.5E 08 0.006
rs1121980 16 52366748 G 0.55  0.152 1.51% 8.8E 08 0.006
rs7193144 16 52368187 T 0.54  0.150 1.48% 1.0E 07 0.006
rs9939609 16 52378028 T 0.54  0.149 1.45% 1.3E 07 0.007
rs9926289 16 52378004 C 0.54  0.145 1.38% 1.4E 07 0.013
rs965670 8 120666727 C 0.95 0.214 0.63% 7.9E 06 0.31
rs1188445 1 30832969 G 0.91  0.217 0.98% 1.1E 05 0.40
Weight rs9930506 16 52387966 A 0.54  0.118 1.34% 9.1E 07 0.10
rs1121980 16 52366748 G 0.55  0.116 1.28% 1.2E 06 0.10
rs8050136 16 52373776 C 0.54  0.115 1.27% 1.2E 06 0.10
rs9940128 16 52358255 G 0.55  0.115 1.26% 1.5E 06 0.10
rs9939973 16 52358069 G 0.55  0.115 1.25% 1.6E 06 0.10
rs7193144 16 52368187 T 0.54  0.114 1.25% 1.6E 06 0.10
rs9939609 16 52378028 T 0.54  0.113 1.22% 2.2E 06 0.11
rs9926289 16 52378004 C 0.54  0.110 1.17% 3.7E 06 0.16
SNP_A-2284869 5 162186248 T 0.85  0.142 1.00% 9.5E 06 0.38
rs6965526 7 85760188 A 0.65  0.105 0.96% 1.6E 05 0.58
All positions refer to the May 2004 genome assembly. The effect is measured in standard deviation units (so that an effect of  0.132 indicates that each additional copy of the allele
decreases trait values by 0.132 standard deviations on average). The H
2 column indicates the proportion of the trait variance that could be explained by the SNP. The FDR column
estimates the proportion of false positives incurred by declaring a particular SNP significant (so that an FDR of 0.09 indicates that declaring all SNPs with a smaller p-value significant is
expected to result in about 9% false-positive findings).
s.d., standard deviation.
doi:10.1371/journal.pgen.0030115.t001
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FTO and Obesitypressure. The families included in this analysis comprise
3,467 individuals in total (1,101 African Americans [AA] in
369 families, 839 Hispanic Americans [HA] in 223 families,
and 1,496 European Americans [EA] in 457 families). Overall,
individuals in GenNet are heavier than those in our original
Sardinian sample. Nevertheless, our ﬁndings strongly conﬁrm
evidence for association between rs9930506 and the three
BMI-related traits (weight, hip circumference, and BMI).
Speciﬁcally, rs9930506 showed association with all three traits
among EA and HA in the GenNet study (meta-analysis of the
EA and HA samples results in a p-value between 0.0005 and
0.001, depending on trait; see Table 3). The association is
signiﬁcant and in the same direction as in our original
sample. The allele frequencies are also similar in all three
samples, with a frequency of 0.46 in our Sardinian sample for
allele ‘‘G’’ of rs9930506 and of 0.44 and 0.33 in the GenNet EA
and HA samples, respectively. In the GenNet sample,
homozygotes for the two rs9930506 alleles differ in weight
by ;1.0 BMI units on average.
We also examined the relationship between rs9930506 and
the three traits in AA, but did not observe evidence for
association within that group. In AA, allele ‘‘G’’ of marker
rs9930506 has a somewhat lower frequency of 0.21. In
addition, AA show quite distinct patterns of linkage
disequilibrium (LD) and thus it is not surprising that the
association does not replicate. For example, in the HapMap
sample of Utah residents with ancestry from northern and
western Europe (CEU), the eight SNPs that show association
Figure 2. Association Results and LD Patterns in Region Surrounding the FTO Gene
(A) Summary of the association between SNPs in the region and BMI. The SNP showing strongest association (rs9930506) is highlighted. Other SNPs are
colored according to their degree of disequilibrium with rs9930506 ranging from high (red), to intermediate (green), to low (blue). Transcripts are
indicated at the bottom of the graph, with an arrow indicating transcript direction.
(B) Summary of the patterns of disequilibrium in the region in Sardinia and in two of the HapMap populations (CEU and YRI) [55]. The grey bar marks
the region of association and facilitates comparisons between the panels.
doi:10.1371/journal.pgen.0030115.g002
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FTO and Obesitywith obesity-related traits in our sample are strongly
associated with each other and tag a total of 38 different
variants (r
2 . 0.80). In contrast, in the HapMap Yoruba in
Ibadan, Nigeria (YRI) the strength of LD in the region is
greatly reduced such that rs9930506 is not in strong LD (r
2 ,
0.3) with any of the other Chromosome 16 SNPs that show
association in Sardinia.
In an attempt to ﬁne-map association in the region, we
decided to genotype the region of strong association in
greater detail. In general, the study of samples from AA
participants can afford an opportunity to ﬁne-map associa-
tion signals and even facilitate identiﬁcation of the causal
variants [38]. As noted above, a total of 38 different variants
are in LD (r
2 . 0.8, HapMap CEU) with the eight SNPs that
are associated with obesity-related traits in our Sardinian
sample. We selected an additional seven SNPs in the region to
tag these 38 variants in samples with reduced LD. Together
with rs9930506, these seven variants capture the other 30
SNPs with r
2 . 0.58 (average r
2 ¼ 0.87, HapMap YRI). The
results are summarized in Table 4 and show that, whereas all
the variants show association in EA and HA, none of the
variants shows association in AA. One possible explanation is
that obesity in AA has a different genetic architecture.
Alternatively, it is possible that because some of the variants
are quite common in EA and HA but rare in AA, much larger
sample sizes will be required to adequately gauge their effects
(for example, rs1421085 and rs3751812 have minor allele
frequencies .0.25 in these ﬁrst two populations, but ,0.11 in
AA).
In contrast to rs9930506, we did not replicate association
between SNP rs6602024 in the PFKP gene and the three
obesity-related traits. The ‘‘A’’ allele was rare in all
Figure 3. Association Results and LD Patterns in Region Surrounding the PFKP Gene
(A) Summary of the association between SNPs in the region and BMI. The SNP showing strongest association (rs6602024) is highlighted. Other SNPs are
colored according to their degree of disequilibrium with rs6602024, ranging from high (orange) to low (blue). Transcripts are indicated at the bottomo f
the graph, with an arrow indicating transcript direction.
(B) Summary of the patterns of disequilibrium in the region in Sardinia and in two of the HapMap populations (CEU and YRI) [55]. The grey bar marks
the region of association and facilitates comparisons between the panels.
doi:10.1371/journal.pgen.0030115.g003
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FTO and Obesitypopulations, with a frequency of 0.12 in our Sardinian
sample, 0.11 in the HA and EA GenNet subsamples and 0.25
in the AA GenNet subsample. The results are summarized in
Table 5 and show that, although homozygotes for the rare
‘‘A’’ allele at rs6602024 were on average heavier by ;1.0–3.0
BMI units than homozygotes for the ‘‘G’’ allele at the SNP,
these homozygotes were rare and, overall, there was no
signiﬁcant association. Corroborating evidence that PFKP
and rs6602024 are associated with BMI is the observation that
a region of ;120 kb including the Pfkp gene has been
implicated in a mouse model of obesity [39] (see Discussion).
A deﬁnite assessment of the impact of PFKP on obesity-
related quantitative traits in human populations will likely
require examination of much larger sample sizes.
Our genotyping results also hint at the possible importance
in Sardinia of other genes previously investigated as
candidates inﬂuencing obesity and related traits (Tables S3–
S5). When we evaluated evidence for association across
previously identiﬁed candidate genes, we observed a small
excess of nominally signiﬁcant p-values. (We tested 837
candidate SNPs in 74 candidate genes against three traits
and found that 145 tests were signiﬁcant at p , 0.05,
corresponding to 5.8% of the 2,511 tests. We observed no
such excess when the whole genome was considered.) Among
the interesting candidates that show association in our
sample are the two adiponectin receptor genes [40] ADIPOR1
(best single SNP p-value¼0.013, 0.027, and 0.016 for BMI, hip
circumference, and weight) and ADIPOR2 (best p-values ¼
0.018, 0.019, 0.013) and the lipoprotein lipase gene, LPL [41]
(best p-values ¼ 0.014, 0.006, 0.018). Nevertheless, all the
association signals observed in any of these previous
candidate genes are far less signiﬁcant than those in FTO or
PFKP.
Discussion
FTO association provides an example of how genome-wide
association studies can point to previously unsuspected
candidate genes. An interstitial deletion overlapping the
region produces human syndromic obesity [34] and a hint
that the gene might be involved in stress responses stems
from the observation that it is down-regulated when the heat
Table 2. Effects Associated with the rs9930506 and rs6602024 SNPs
Gene/SNP Genotype Class Frequency Genotype Means
Weight (kg) Hip (cm) BMI (kg/m
2)
FTO/rs9930506 G/G 0.21 69.8 101.0 27.9
G/A 0.50 67.3 99.7 26.9
A/A 0.29 66.7 98.3 26.4
Estimated additive effect
a 0.46 (G) 1.636 1.349 0.662
PFPK/rs6602024 A/A 0.01 75.6 103.2 30.6
A/G 0.21 68.0 100.2 27.4
G/G 0.77 67.2 99.2 26.7
Estimated additive effect
a 0.12 (A) 2.194 1.296 0.906
aEffect was estimated in a variance component model including sex, age, age
2, and (except for BMI) height as covariates.
doi:10.1371/journal.pgen.0030115.t002
Table 3. Replication of Association between rs9930506/FTO/G Allele and Obesity-Related Traits
Sample Average BMI BMI Weight Hip
A/A A/G G/G Associated
Effect (s.d.)
p-Value Associated
Effect (s.d.)
p-Value Associated
Effect (s.d.)
p-Value
Sardinia 26.4(4.1) 26.9(4.5) 27.9(5.1) þ0.132 0.00000086 þ0.118 0.00000091 þ0.157 0.000000034
EA
a 28.9(6.6) 28.6(6.2) 30.5(7.0) þ0.080 0.03 þ0.071 0.03 þ0.106 0.006
HA
a 28.4(6.0) 28.8(6.3) 29.7(7.1) þ0.122 0.03 þ0.104 0.03 þ0.096 0.08
AA
a 30.1(8.1) 30.8(8.5) 30.4(8.7)  0.004 0.9  0.006 0.5  0.009 0.4
Combined GenNet EA and
HA (but excluding Sardinia)
— — — — 0.001 — 0.001 — 0.0005
Combined GenNet EA, HA, and
AA (but excluding Sardinia)
— — — — 0.007 — 0.015 — 0.012
The table summarizes the effect of allele ‘‘G’’ for rs9930506 in the original sample and in each of the replication samples examined. The allele has a frequency of 0.46 in our Sardinian
sample and of 0.44, 0.33, and 0.21 in the EA, HA, and AA GenNet subsamples, respectively. Average BMI and standard deviation (inside parenthesis) is reported for each genotype class.
The effect size (in standard deviation units, after normalizing the data and adjusting for covariates) and significance of the observed association is reported for each sample. Note that,
although the effect observed in Sardinia is slightly larger than in the replication samples when measured in standard deviation units, the replication samples also appear to show greater
variability in trait values overall (as seen by the larger standard deviations within each genotype class). The combined p-values are one-sided and test for an effect that is in the same
direction as that seen in Sardinia.
aGenNet Family Blood Pressure Study.
s.d., standard deviation.
doi:10.1371/journal.pgen.0030115.t003
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FTO and Obesityshock response transcription factor Htf1 is inhibited [42].
Because the gene has no recognizable functional domains and
has not been studied in detail in experimental models, no
putative function can be currently imputed. The fact that
FTO is associated not only with BMI but also with hip
circumference and weight is consistent with previous analyses
of heritability in our cohort [20]. The analyses suggested that
80% of the genetic variance of these traits is determined by
common loci (individually, the traits have heritabilities
between ;30%–45%). Although the three traits examined
here are correlated (all pairwise correlations were .0.73), it is
important to note that apart from the SNPs that overlap FTO,
other strongly associated SNPs differed among the traits (see
Tables 1 and S2).
In contrast to FTO, PFKP is a critical enzyme within the
well-studied pathway of glucose metabolism but, to our
knowledge, has not been previously implicated in obesity in
humans. PFKP is one of the three phosphofructokinase
subunit proteins that show partially overlapping patterns of
expression and form hetero-tetramers in diverse cells and
tissues. The subunits are encoded by different genes. One
form is highly expressed in muscle (PFKM); a second, in liver
(PFKL); and the third, PFKP, is the only form in platelets and
is also highly expressed in subregions of the brain [42]. None
Table 4. Fine-Mapping Results for FTO Region in GenNet Sample
Trait Marker Allele EA BMI HA BMI AA BMI
Frequency Effect Standard
Error
p-Value Frequency Effect Standard
Error
p-Value Frequency Effect Standard
Error
p-Value
BMI rs1421085 T 0.58  0.122 0.039 0.002 0.75  0.155 0.055 0.005 0.92  0.062 0.084 0.5
rs9937053 G 0.58  0.103 0.038 0.007 0.65  0.095 0.051 0.06 0.58 0.050 0.047 0.3
rs8043757 A 0.59  0.120 0.039 0.002 0.71  0.118 0.053 0.03 0.57 0.033 0.045 0.5
rs3751812 G 0.59  0.115 0.039 0.003 0.74  0.142 0.055 0.01 0.89  0.023 0.076 0.8
rs9923233 G 0.55  0.122 0.039 0.002 0.71  0.112 0.053 0.03 0.51 0.061 0.044 0.2
rs9932754 T 0.55  0.088 0.038 0.02 0.71  0.117 0.052 0.03 0.79  0.045 0.051 0.4
rs9922619 G 0.56  0.089 0.038 0.02 0.68  0.107 0.052 0.04 0.82  0.002 0.056 1
Hip rs1421085 T 0.58  0.143 0.039 0.0002 0.75  0.068 0.049 0.03 0.92  0.025 0.082 0.8
rs9937053 G 0.58  0.125 0.038 0.0009 0.65  0.117 0.053 0.2 0.58 0.038 0.045 0.4
rs8043757 A 0.59  0.143 0.038 0.0002 0.71  0.085 0.052 0.1 0.57 0.019 0.044 0.7
rs3751812 G 0.59  0.138 0.039 0.0004 0.74  0.105 0.053 0.05 0.89  0.011 0.074 0.9
rs9923233 G 0.55  0.145 0.038 0.00014 0.71  0.081 0.052 0.12 0.51 0.047 0.043 0.3
rs9932754 T 0.55  0.111 0.038 0.003 0.71  0.096 0.051 0.06 0.79  0.037 0.05 0.5
rs9922619 G 0.56  0.113 0.038 0.003 0.68  0.083 0.051 0.1 0.82  0.004 0.054 0.9
Weight rs1421085 T 0.58  0.104 0.035 0.003 0.75  0.141 0.049 0.004 0.92  0.059 0.084 0.5
rs9937053 G 0.58  0.089 0.034 0.008 0.65  0.087 0.045 0.06 0.58 0.051 0.047 0.3
rs8043757 A 0.59  0.100 0.034 0.003 0.71  0.107 0.048 0.03 0.57 0.031 0.046 0.5
rs3751812 G 0.59  0.095 0.034 0.006 0.74  0.128 0.049 0.01 0.89  0.018 0.076 0.8
rs9923233 G 0.55  0.101 0.034 0.003 0.71  0.103 0.048 0.03 0.51 0.061 0.045 0.2
rs9932754 T 0.55  0.074 0.034 0.03 0.71  0.105 0.047 0.02 0.79  0.044 0.051 0.4
rs9922619 G 0.56  0.075 0.034 0.03 0.68  0.095 0.047 0.04 0.82 0.001 0.056 1
Additional SNPs in the region that shows strong association in Sardinia and in the HapMap CEU sample were examined in an attempt to fine-map association within the GenNet AA
sample. The frequency of each allele examined, its associated effect (in standard deviation units), and corresponding p-value are summarized.
doi:10.1371/journal.pgen.0030115.t004
Table 5. Replication of Association between rs6602024/PFKP/A Allele and Obesity-Related Traits
Sample Average BMI BMI Weight Hip
G/G A/G A/A Effect p-Value Effect p-Value Effect p-Value
Sardinia 26.7(4.5) 27.3(4.6) 30.6(4.9) 0.196 .0000049 0.167 .000016 0.113 0.00047
EA
a 28.9 (6.4) 29.5(6.9) 32.2(6.8) 0.071 0.3 0.075 0.2 0.083 0.2
HA
a 28.8(6.4) 28.4(6.0) 31.2(7.8) 0.000 0.9 0.008 1  0.034 0.6
AA
a 29.9(8.3) 30.9(8.4) 30.9(8.4) 0.055 0.3 0.042 0.4 0.071 0.2
Combined GenNet EA and
HA (but excluding Sardinia)
— — — — 0.225 — 0.152 — 0.238
Combined GenNet EA, HA
and AA (but excluding Sardinia)
— — — — 0.094 — 0.094 — 0.098
The table is analogous to Table 3, but focuses on allele ‘‘A’’ for the rs6602024 SNP. The allele has a frequency of 0.12 in our Sardinian sample, 0.11 in the EA and HA GenNet subsamples,
and 0.25 in the AA GenNet subsample. We did not find a significant additive effect for this allele in the replication samples. However, note that homozygotes for the ‘‘A’’ allele are
consistently heavier than individuals with a ‘‘G/G’’ genotype. There are 72 such homozygotes in the replication sample (nine EA, ten HA, and 53 AA).
aGenNet Family Blood Pressure Study.
doi:10.1371/journal.pgen.0030115.t005
PLoS Genetics | www.plosgenetics.org July 2007 | Volume 3 | Issue 7 | e115 1207
FTO and Obesityof the forms has been previously implicated in obesity in
humans, although PFKM is mutated in some cases of impaired
glycogen synthesis (glycogen storage disease VII; see Online
Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/
entrez/dispomim.cgi?id¼232800) [35]. It is of considerable
interest that compared to the other isozymes, PFKP has lower
afﬁnity for fructose-6-phosphate and decreased inhibition by
ATP [43]. Consequently, PFKP is the most stringently
regulated, responding to small changes at typical metabolic
levels of effectors [44]. Genetic variants in the enzyme could
thus adjust the rate of glycolysis, shifting the balance of
metabolism between gluconeogenesis and glucose assimila-
tion—a possible step in the etiology of obesity. Additionally,
it is intriguing that in mice a locus associated with obesity has
been mapped to a 127-kb interval that includes Pfkp [39]. The
mouse locus shows strong evidence of interaction with diet,
with different effects in mice fed high-fat and low-fat diets.
One possibility is that greater homogeneity of diet in Sardinia
facilitated mapping, but made replication in other popula-
tions more difﬁcult.
How signiﬁcant are the associations observed? The repli-
cation of the FTO association in two different populations
indicates that it is likely important not only in Sardinia, but
in many different populations. In contrast, the failure to
replicate the PFKP association in other populations suggests
that (a) the association we identiﬁed may refer to rarer,
population-speciﬁc variants; (b) the effects of the locus may
depend on genetic or environmental background; or (c) the
association identiﬁed in our original sample is due to the
statistical ﬂuctuations inherent in testing hundreds of
thousands of SNPs. As for the public health impact of the
observed associations, a 1-unit increment in BMI has been
associated with an 8% increase in the risk of coronary heart
disease [45] and excess weight in middle life is associated with
increased overall risk of death [46]. Thus, the alleles reported
here, which shift BMI by 1–1.5 units, have effects that are not
only statistically signiﬁcant but could also have important
health consequences. Furthermore, apart from the direct
contribution of these gene variants, they provide an entre ´eto
the analysis of genes and pathways that contribute addition-
ally, and open new routes to possible eventual intervention.
Note: After completing this manuscript, we became aware of
additional evidence that supports our report of association
between FTO and obesity-related traits. First, genotyping of
1,780 individuals from the SUVIMAX study [47,48] replicated
association of allele rs9930506 with increased BMI (p¼0.006).
Combined evidence from SUVIMAX, GenNet EA, and
GenNet HA resulted in a replication p-value of 1.5 3 10
 5.
In addition, two other large independent studies also show
association of SNPs in FTO with increased BMI [49,50].
Genotyping of the SUVIMAX sample did not provide
evidence for association between rs6602024 and BMI.
Materials and Methods
Study sample. We recruited and phenotyped 6,148 individuals,
male and female, ages 14–102 y, from a cluster of four towns in the
Lanusei Valley [20]. During physical examination of each individual, a
blood sample was collected (for DNA extraction) and anthropometric
traits were recorded. Here, we report analyses of hip circumference,
weight, and the derived quantity BMI (which is calculated from a
combination of height and weight). Genotyping was carried out using
the Affymetrix 10K and 500K chips (http://affymetrix.com/) using
standard protocols. Summary assessments of genotype data quality
are provided in the Results section and in Table S1.
To follow up on SNPs rs9930506 and rs6602024, we genotyped and
examined the association between these two SNPs and BMI, hip
circumference, and body weight in the GenNet study. The study
comprises 3,467 individuals in total, recruited between 1995 and 2004
(1,101 AA, 839 HA, and 1,496 EA). Individuals were recruited at two
ﬁeld centers: EA were recruited from Tecumseh, Michigan, and AA
and HA were recruited from Maywood, Illinois. Participants were
recruited from families starting from a proband with high blood
pressure. DNA was available for 3,205 individuals (968 AA, 824 HA,
and 1471 EA). SNP genotyping was performed using the 59-nuclease–
based assay (TaqMan; ABI, http://www.appliedbiosystems.com/) ana-
lyzed on an ABI Prism 7900 Real Time PCR System. Within each
ethnic group, genotype completeness rates exceed 98% and there was
no evidence for deviation from Hardy–Weinberg equilibrium (p .
0.05).
Statistical analysis. To ensure adequate control of type I error
rates, we applied an inverse normal transformation to each trait prior
to analysis [20]. The inverse normal transformation reduces the
impact of outliers and deviations from normality on statistical
analysis. The transformation involves ranking all available pheno-
types, transforming these ranks into quantiles and, ﬁnally, converting
the resulting quantiles into normal deviates. We included sex, age,
and age
2 as covariates in all analysis. Height was signiﬁcantly
associated with weight and hip circumference and was included as
an additional covariate in analysis of those traits. We ﬁtted a simple
regression model to each trait and used a variance component
approach to account for correlation between different observed
phenotypes within each family. For individuals who had genotype
data available, we coded genotypes as 0, 1, and 2 (depending on the
number of copies of the allele being tested). For individuals with
missing genotype data, we used the Lander–Green algorithm to
estimate an expected genotype score (between 0 and 2) for each
individual [24]. Brieﬂy, to estimate each genotype score we ﬁrst
calculate the likelihood of the observed genotype data. Then, we
instantiate each missing genotype to a speciﬁc value and update the
pedigree likelihood. The ratio of the two likelihoods gives a posterior
probability that the instantiated genotype is true, conditional on all
available data. Due to computational constraints, we divided large
pedigrees into subunits with ‘‘bit-complexity’’ of 19 or less (typically,
20–25 individuals) before estimating missing genotypes.
Our analytical approach considers all observed or estimated
genotypes (rather than focusing on alleles transmitted from hetero-
zygous parents) and thus is not immune to effects of population
stratiﬁcation. In homogenous populations, this type of analysis is
expected to be more powerful [51,52]. To adjust for the effects of
population structure and cryptic relatedness among sampled
individuals, we used the genomic control method to adjust our test
statistics for each trait separately [29]. FDRs were calculated with R’s
p.adjust() procedure using the method of Benjamini and Hochberg
[30]. Since the initial analysis often identiﬁed clusters of nearby SNPs
that all showed similar levels of association, we also carried out a
sequential stepwise analysis. In this analysis, we selected the best SNP
for each trait, and then conditioned on it to successively select the
next best SNP. This sequential analysis can help identify regions with
multiple independent association signals. The stepwise analysis was
repeated for ﬁve rounds.
Candidate gene analysis. We selected 74 candidate genes pre-
viously tested for association with obesity in humans [53]. For each
gene, we ﬁrst evaluated the ability of the Affymetrix SNPs to tag
common SNPs (MAF . 0.05) withinþ/ 5 kb of the gene (r
2 . 0.50 or
r
2 . 0.80) using the HapMap CEU database [54]. We then evaluated
evidence for association using all Affymetrix SNPs within each gene
as well as neighboring Affymetrix SNPs that could be used to improve
coverage (r
2 . 0.5). For each gene, we report coverage statistics as well
as the SNP that showed strongest evidence for association.
We selected 74 genes that were previously targeted in associations
studies aiming to identify genetic determinants of obesity in humans
[53]: ACE, ACTN, ADIPOQ, ADIPOR1, ADIPOR2, ADRB1, ADRB2,
AGER, AHSG, APOA2, APOA4, APOA5, AR, BDNF, CASQ1, COL1A1,
COMT, CRP, CYP11B2, DIO1, ENPP1, ESR1, ESR2, FABP2, FOXC2,
GAD2, GFPT1, GHRHR, GNAS, GNB3, GPR40, H6PD, HSD11B1,
HTR2C, ICAM1, IGF1, IGF2, IL6, IL6R, KCNJ11, KL, LEP, LEPR, LIPC,
LPL, LTA, MC4R, MCHR1, MKKS, MTHFR, MTTP, NMB, NOS3, NPY,
NPY2R, NR0B2, NTRK2, PARD6A, PLIN, PPARG, PPARGC1A, PRDM2,
PTPN1, PYY, RETN, SCD, SELE, SERPINE1, TAS2R38, TNF, UCP1,
UCP2, UCP3, and VDR. We did not consider genes associated with
drug-induced body weight gain or mitochondrial genes [53].
The following genes have previously been investigated for their
PLoS Genetics | www.plosgenetics.org July 2007 | Volume 3 | Issue 7 | e115 1208
FTO and Obesityrole in obesity and related traits but are not well tagged by SNPs in
the Affymetrix array: ADRB3, DRD4, INS, and APOE.
Supporting Information
Table S1. Genotype Data for Sardinian Cohort
Found at doi:10.1371/journal.pgen.0030115.st001 (47 KB DOC).
Table S2. Results of Stepwise Analysis to Identify Independent Risk
Alleles
To generate this table, we ﬁrst sought the most signiﬁcantly
associated allele in the genome. We then added this allele to our
baseline model and repeated our genome scan to identify the next
associated SNPs.
Found at doi:10.1371/journal.pgen.0030115.st002 (55 KB DOC).
Table S3. Tag SNP That Shows Strongest Association with BMI for
Each Previously Identiﬁed Candidate Gene
The ﬁrst column indicates the name of a previously identiﬁed
candidate. The second column indicates the number of SNPs in our
Affymetrix arrays that are either in the gene or constitute the best
available tag (r
2 . 0.5) for a genic SNP. The next column indicates the
number of HapMap SNPs within þ/  5 kb of the gene and the
proportion of these that are covered at r
2 . 0.50 or r
2 . 0.80. The
next columns indicate the SNP that showed strongest association in
our analysis, the p-value, the tested allele and its frequency, and the
estimated additive effect. The last column corresponds to the FDR
incurred when all tested SNPs are considered and this test is declared
signiﬁcant.
Found at doi:10.1371/journal.pgen.0030115.st003 (162 KB DOC).
Table S4. Tag SNP That Shows Strongest Association with Hip
Circumference for Each Previously Identiﬁed Candidate Gene
The ﬁrst column indicates the name of a previously identiﬁed
candidate. The second column indicates the number of SNPs in our
Affymetrix arrays that are either in the gene or constitute the best
available tag (r
2 . 0.5) for a genic SNP. The next column indicates the
number of HapMap SNPs within þ/  5 kb of the gene and the
proportion of these that are covered at r
2 . 0.50 or r
2 . 0.80. The
next columns indicate the SNP that showed strongest association in
our analysis, the p-value, the tested allele and its frequency, and the
estimated additive effect. The last column corresponds to the FDR
incurred when all tested SNPs are considered and this test is declared
signiﬁcant.
Found at doi:10.1371/journal.pgen.0030115.st004 (163 KB DOC).
Table S5. Tag SNP That Shows Strongest Association with Weight for
Each Previously Identiﬁed Candidate Gene
The ﬁrst column indicates the name of a previously identiﬁed
candidate. The second column indicates the number of SNPs in our
Affymetrix arrays that are either in the gene or constitute the best
available tag (r
2 . 0.5) for a genic SNP. The next column indicates the
number of HapMap SNPs within þ/  5 kb of the gene and the
proportion of these that are covered at r
2 . 0.50 or r2 . 0.80. The
next columns indicate the SNP that showed strongest association in
our analysis, the p-value, the tested allele and its frequency, and the
estimated additive effect. The last column corresponds to the FDR
incurred when all tested SNPs are considered and this test is declared
signiﬁcant.
Found at doi:10.1371/journal.pgen.0030115.st005 (163 KB DOC).
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